Commercial model

Reimagining Pharma’s Commercial Model: From National Playbooks to Local Agility

Q: What is a pharma commercial model, and why is it changing?

A pharma commercial model defines how pharmaceutical companies engage healthcare providers, payers, and patients to drive growth. It is changing because traditional, centralized approaches cannot keep pace with today’s complex, digital, and locally driven healthcare environment.

Q: What is the agile local deployment model in the pharmaceutical industry?

The agile local deployment model empowers cross-functional teams, led by a Micro-enterprise General Manager (MEGM), to make decisions and allocate resources based on the specific needs of individual local healthcare markets.

Q: How does localization in pharma improve commercial outcomes?

Localization allows teams to tailor strategies to local market needs, enabling faster responses, stronger relationships between providers and patients, and greater overall commercial impact.

Q: What challenges do traditional pharma commercial models face with IDNs and payers?

Traditional models often struggle with slow adaptation, siloed teams, and a loss of influence, making it difficult to impact access and adoption within integrated delivery networks and payer organizations.

Q: How can pharma companies balance profitability with localized engagement?

Pharma companies can balance profitability and localized engagement by empowering local leaders, leveraging data-driven decision-making, and maintaining a strong focus on return on investment while addressing local market needs.

Q: What challenges do companies face when transitioning to this new model?

Common challenges include breaking down organizational silos, shifting mindsets from a national to a local perspective, and embedding financial discipline and data-driven decision-making at the local level.

Q: What actionable steps are recommended for companies starting this transformation?

Companies should start with small local pilots, empower local leaders, integrate digital and AI tools, and scale successful approaches to achieve sustainable growth.

Download White Paper

Is your commercial model keeping up?

In today’s rapidly evolving life sciences landscape, traditional commercial models are falling short. Commercial operations leaders face mounting challenges:

Slow adaptation to local market shifts due to bureaucracy and rigid hierarchies
Fragmented engagement from siloed teams
Intense pressure to deliver growth and profitability in a digitally disrupted, highly regulated environment

Forward-thinking organizations are leading the way by adopting a local ecosystem-tailored deployment model called Local Ecosystem Customer Engagement (LECE), empowering cross-functional teams with the autonomy and tools to respond to unique market needs.

This white paper, co-authored by an industry expert, Eren Sakinc, (currently Senior Director, Field Analytics and Effectiveness, Sanofi) and experts at Axtria, reveals how Local Ecosystem Customer Engagement (LECE) models are transforming commercial operations and driving measurable results.

What you’ll discover in this white paper

Break Free from Outdated Playbooks:  Learn why national, activity-based models are holding your teams back and how to pivot to local market-driven, agile strategies.
Accelerate Growth with Agile Local Deployment:  See how cross-functional, locally accountable teams drive faster, more profitable results in complex healthcare environments.
Actionable Insights for Leaders:  Transform operations across six dimensions—from strategy and AI to talent and patient focus—using omnichannel engagement and modular, AI-driven orchestration to stay ahead.

Why download?

Real-World Insights:  Featuring proven strategies from industry experts and Axtria leaders.
Immediate Value:  Actionable recommendations you can pilot locally and scale for lasting impact.
Set the Standard:  Those who act now will not only remain competitive but will define commercial excellence in life sciences.

Ready to transform your commercial operations?

Download the white paper to discover how leading pharmaceutical companies are redefining commercial models, with real-world client insights and proven strategies for life sciences growth.

This white paper is designed for senior leaders in life sciences responsible for commercial strategy, field force effectiveness, and go-to-market execution including VPs and SVPs in Commercial Operations, Commercial Excellence, Sales Operations, and Market Access, as well as Directors and Senior Directors driving local engagement, ecosystem strategy, and cross-functional field team performance.